The Register Risers · Updated as filings land

The UK private companies investors keep marking up.

Download

Every priced funding round a UK private company raises is filed at Companies House on form SH01. We read those filings and rank the companies whose share price rose between rounds. No press releases, no self-reporting: only what was filed, and every figure links to its source document.

Exhibit 1

Ranked by latest implied valuation; every company here rose between rounds

35 of 47 tracked companies rose · data as of 27 August 2026
#CompanySectorStep-upOverRaisedImplied valuationLast round
1
London · AI video generation
Software & AI
126x
80 mo
£336.9m
£2.6bn
Dec 2025
2
London · food delivery
Consumer
7.6x
20 mo
£161.0m
£501.1m
Jun 2021
3
Farnborough · children's banking app
Fintech
8.4x
140 mo
£157.0m
£317.5m
Sept 2022
4
Cambridge · legal AI
Software & AI
2.9x
109 mo
£111.1m
£309.9m
Feb 2025
5
London · software group
Software & AI
32x
42 mo
£57.6m
£239.3m
Feb 2026
6
London · virtual wards and remote monitoring
Biotech & health
6.7x
35 mo
£39.4m
£141.8m
Jul 2024
7
Cardiff · neuroscience therapeutics
Biotech & health
1.6x
19 mo
£117.0m
£125.5m
Apr 2026
8
Milton Keynes · software
Software & AI
3.4x
21 mo
£17.3m
£81.0m
Jan 2026
9
London · industrial technology
Deep tech
2.4x
15 mo
£26.2m
£79.6m
Feb 2026
10
London · cloud services
Software & AI
1.2x
15 mo
£28.1m
£72.4m
Mar 2025
11
London · AI customer operations
Software & AI
3.3x
35 mo
£27.5m
£65.8m
Jun 2026
12
Edinburgh · battery cell monitoring chips
Deep tech
3.3x
186 mo
£43.4m
£65.6m
Jun 2026
13
Mansfield · computational protein engineering
Biotech & health
5.6x
34 mo
£32.2m
£62.0m
Sept 2023
14
London · healthcare staffing marketplace
Consumer
2.7x
103 mo
£25.8m
£59.8m
Oct 2025
15
Stevenage · neurodegeneration therapeutics
Biotech & health
1.3x
44 mo
£47.2m
£58.5m
Feb 2026
16
London · AI for real estate
Software & AI
3.1x
31 mo
£28.4m
£57.8m
Apr 2026
17
London · gene therapies for solid tumours
Biotech & health
1.7x
20 mo
£31.6m
£49.9m
Oct 2025
18
London · content moderation AI
Software & AI
4.4x
61 mo
£10.9m
£47.5m
Apr 2026
19
London · expert research platform
Software & AI
3.8x
63 mo
£15.9m
£46.0m
Oct 2023
20
Altrincham · cell therapy R&D
Biotech & health
1.2x
36 mo
£30.4m
£41.7m
May 2026
21
London · AI software
Software & AI
1.3x
27 mo
£16.9m
£40.1m
Apr 2026
22
London · precision medicine research platform
Biotech & health
8.1x
86 mo
£22.7m
£37.7m
Feb 2026
23
London · AI audio production
Software & AI
2.4x
46 mo
£11.5m
£36.2m
Feb 2026
24
Belfast · scientific sales intelligence
Software & AI
6.4x
64 mo
£16.0m
£36.1m
Sept 2025
25
London · API security
Software & AI
4.2x
78 mo
£22.3m
£36.0m
Apr 2023
26
Cambridge · targeted protein degradation
Biotech & health
1.2x
18 mo
£27.1m
£34.9m
Jun 2026
27
London · legal transaction visualisation
Software & AI
7.3x
18 mo
£4.2m
£34.9m
Jan 2021
28
Stanhope · UK lithium extraction
Deep tech
60x
47 mo
£3.6m
£31.5m
Jul 2024
29
London · savings and pensions platform
Fintech
1.5x
42 mo
£4.6m
£29.3m
May 2026
30
Altrincham · therapeutics R&D
Biotech & health
12x
44 mo
£17.2m
£29.1m
Nov 2024
31
London · branded butter
Consumer
4.0x
33 mo
£8.2m
£26.2m
Jun 2026
32
London · Islamic vehicle finance
Fintech
12x
14 mo
£3.9m
£26.1m
Feb 2025
33
London · sports fan engagement
Consumer
5.9x
126 mo
£13.1m
£24.8m
Jul 2026
34
Oxford · natural hydrogen exploration
Deep tech
1.4x
24 mo
£19.5m
£24.6m
Jul 2025
35
Bristol · automated wiring manufacture
Deep tech
2.2x
47 mo
£11.8m
£21.0m
Nov 2025
Source: Companies House, priced allotments filed on form SH01; Tero analysis, 27 August 2026. Step-up is the latest priced round divided by the first substantive priced round; option-scheme and nominal issues are excluded. Bar lengths are drawn on a square-root scale so the largest values do not flatten the rest; the printed number is the figure. Implied valuation is price per share times shares in issue after the latest priced allotment. Information, not investment advice.